{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:03:52Z","timestamp":1793037832335,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005326","name":"Yale University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01TW008764-02"],"award-info":[{"award-number":["K01TW008764-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jdcr.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T12:55:24Z","timestamp":1573649724000},"page":"1018-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib"],"prefix":"10.1016","volume":"5","author":[{"given":"William E.","family":"Damsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred Ian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Claire","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","article-title":"Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome","volume":"139","author":"Choquet-Kastylevsky","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jid.2018.10.048","article-title":"Increased type 2 innate lymphoid cells in patients with drug reaction with eosinophilia and systemic symptoms syndrome","volume":"139","author":"Tsai","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"5163129","DOI":"10.1155\/2018\/5163129","article-title":"Recent Advances in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"2018","author":"Watanabe","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jdcr.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1038\/s41467-018-06316-9","article-title":"Eosinophil recruitment is dynamically regulated by interplay among lung dendritic cell subsets after allergen challenge","volume":"9","author":"Yi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jdcr.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bbrc.2011.03.097","article-title":"Small molecule antagonists of CCR8 inhibit eosinophil and T cell migration","volume":"407","author":"Karlsson","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdcr.2019.07.004_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ACI.0000000000000180","article-title":"Monitoring the acute response in severe hypersensitivity reactions to drugs","volume":"15","author":"Shiohara","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000475546","article-title":"Skin-homing IL-13-producing T cells expand in the circulation of patients with drug rash with eosinophilia and systemic symptoms","volume":"233","author":"Teraki","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.jdcr.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0002-9343(86)90371-2","article-title":"Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis","volume":"81","author":"Engel","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.jdcr.2019.07.004_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jid.2016.10.044","article-title":"Treatment of hypereosinophilic syndrome with cutaneous involvement with the JAK inhibitors tofacitinib and ruxolitinib","volume":"137","author":"King","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"709.e1","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part II. Management and therapeutics","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMcpc079030","article-title":"Case records of the Massachusetts General Hospital. Case 36-2007. A 31-year-old woman with rash, fever, and hypotension","volume":"357","author":"Sabatine","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/0002-9343(86)90371-2","article-title":"Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis","volume":"81","author":"Engel","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS3","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS4","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMcpc079030","article-title":"Case records of the Massachusetts General Hospital. Case 36-2007. A 31-year-old woman with rash, fever, and hypotension","volume":"357","author":"Sabatine","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS5","first-page":"764","article-title":"Hypersensitivity myocarditis","volume":"115","author":"Burke","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (dress): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS7","doi-asserted-by":"crossref","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS8","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1212\/NXI.0000000000000479","article-title":"Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS","volume":"5","author":"Scheibe","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jdcr.2019.07.004_bibS9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jdv.12419","article-title":"Recurrence of drug-induced reactions in DRESS patients","volume":"29","author":"Picard","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619303571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512619303571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:20:46Z","timestamp":1762474846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512619303571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2352512619303571"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.07.004","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}